Mosunetuzumab

Mosunetuzumab, also known by its brand name Lunsumio, is a medication given as an IV (intravenous) infusion. This treatment is designed to help your body's immune system find and remove lymphoma cells. It works by acting like a bridge, connecting your immune cells directly to the cancer cells so your body can target them more effectively. You'll receive this therapy in regular cycles, often starting with smaller doses that gradually increase to help manage potential side effects. For many patients, this treatment is given for a specific length of time. This topic offers supportive information about what you can expect during your Mosunetuzumab treatment.